Abstract
The latest chapter of the historic battle of humans against pathogenic microbes is the severe acute respiratory syndrome (SARS)-like coronavirus-2 (SARS-CoV-2), responsible for COVID-19, a respiratory disease declared a global pandemic by the WHO on March 11, 2020 [...].
MeSH terms
-
Anti-Inflammatory Agents / isolation & purification
-
Anti-Inflammatory Agents / pharmacology*
-
Anti-Inflammatory Agents / therapeutic use
-
Antimicrobial Cationic Peptides / isolation & purification
-
Antimicrobial Cationic Peptides / pharmacology
-
Antimicrobial Cationic Peptides / therapeutic use
-
Antiviral Agents / isolation & purification
-
Antiviral Agents / pharmacology*
-
Antiviral Agents / therapeutic use
-
Aquatic Organisms / chemistry*
-
Biological Products / isolation & purification
-
Biological Products / pharmacology*
-
Biological Products / therapeutic use
-
COVID-19 / epidemiology
-
COVID-19 / immunology
-
COVID-19 / prevention & control
-
COVID-19 / virology
-
COVID-19 Drug Treatment*
-
COVID-19 Vaccines / administration & dosage
-
Depsipeptides / isolation & purification
-
Depsipeptides / pharmacology
-
Depsipeptides / therapeutic use
-
Humans
-
Pandemics / prevention & control
-
Peptides, Cyclic / isolation & purification
-
Peptides, Cyclic / pharmacology
-
Peptides, Cyclic / therapeutic use
-
SARS-CoV-2 / drug effects
-
SARS-CoV-2 / immunology
-
Seawater / microbiology
-
Virus Attachment / drug effects
Substances
-
Anti-Inflammatory Agents
-
Antimicrobial Cationic Peptides
-
Antiviral Agents
-
Biological Products
-
COVID-19 Vaccines
-
Depsipeptides
-
Peptides, Cyclic
-
gallinamide A
-
plitidepsin